18F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non–small cell lung cancer
RJ Hicks, V Kalff, MP MacManus, RE Ware… - Journal of Nuclear …, 2001 - Soc Nuclear Med
Survival of lung cancer patients remains poor despite increasingly aggressive treatment.
Conventional staging has well-described limitations. 18F-FDG PET has been shown to …
Conventional staging has well-described limitations. 18F-FDG PET has been shown to …
The utility of 18F-FDG PET for suspected recurrent non–small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification
RJ Hicks, V Kalff, MP MacManus, RE Ware… - Journal of Nuclear …, 2001 - Soc Nuclear Med
After potentially curative therapy of non–small cell lung cancer (NSCLC), masses or
symptoms suggestive of relapse are common but may be difficult to characterize. Early …
symptoms suggestive of relapse are common but may be difficult to characterize. Early …
Impact of initial PET/CT staging in terms of clinical stage, management plan, and prognosis in 592 patients with non-small-cell lung cancer
S Takeuchi, B Khiewvan, PS Fox, SG Swisher… - European journal of …, 2014 - Springer
Purpose Our objective was to determine the impact of initial 18 F-FDG PET/CT (PET/CT)
staging on clinical stage and the management plan and the prognostic value of PET/CT in …
staging on clinical stage and the management plan and the prognostic value of PET/CT in …
Effect of PET/CT on management of patients with non–small cell lung cancer: results of a prospective study with 5-year survival data
DL Gregory, RJ Hicks, A Hogg, DS Binns… - Journal of Nuclear …, 2012 - Soc Nuclear Med
We investigated the incremental management impact and prognostic value of staging with
18F-FDG PET/CT in patients with non–small cell lung cancer (NSCLC) being considered for …
18F-FDG PET/CT in patients with non–small cell lung cancer (NSCLC) being considered for …
Thoracic staging with 18F-FDG PET/MR in non-small cell lung cancer – does it change therapeutic decisions in comparison to 18F-FDG PET/CT?
BM Schaarschmidt, J Grueneisen, M Metzenmacher… - European …, 2017 - Springer
Objective To investigate whether differences in thoracic tumour staging between 18 F-FDG
PET/CT and PET/MR imaging lead to different therapeutic decisions in Non-Small Cell Lung …
PET/CT and PET/MR imaging lead to different therapeutic decisions in Non-Small Cell Lung …
[HTML][HTML] Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancer
J Cuaron, M Dunphy, A Rimner - Frontiers in oncology, 2013 - frontiersin.org
The integral role of positron-emission tomography (PET) using the glucose analog tracer
fluorine-18 fluorodeoxyglucose (FDG) in the staging of non-small cell lung cancer (NSCLC) …
fluorine-18 fluorodeoxyglucose (FDG) in the staging of non-small cell lung cancer (NSCLC) …
F‐18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with …
BACKGROUND Successful treatment of nonsmall cell lung carcinoma (NSCLC) with radical
radiotherapy (RT) requires accurate delineation of tumor extent. Conventional computed …
radiotherapy (RT) requires accurate delineation of tumor extent. Conventional computed …
Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT
P Heusch, C Buchbender, J Köhler… - Journal of Nuclear …, 2014 - Soc Nuclear Med
Therapeutic decisions in non–small cell lung cancer (NSCLC) patients depend on the tumor
stage. PET/CT with 18F-FDG is widely accepted as the diagnostic standard of care. The …
stage. PET/CT with 18F-FDG is widely accepted as the diagnostic standard of care. The …
18F-FDG PET/CT: therapy response assessment interpretation (Hopkins criteria) and survival outcomes in lung cancer patients
S Sheikhbahaei, E Mena, C Marcus… - Journal of Nuclear …, 2016 - Soc Nuclear Med
The purpose of this study was to evaluate the value of an 18F-FDG PET/CT–based
interpretation system (Hopkins criteria) to assess the therapy response and survival in lung …
interpretation system (Hopkins criteria) to assess the therapy response and survival in lung …
The impact of PET on the management of lung cancer: the referring physician's perspective
MA Seltzer, CS Yap, DH Silverman, J Meta… - Journal of Nuclear …, 2002 - Soc Nuclear Med
18F-FDG PET is a molecular whole-body imaging modality that is increasingly being used
for diagnosing, staging, and restaging cancer. The objective of this study was to determine …
for diagnosing, staging, and restaging cancer. The objective of this study was to determine …
相关搜索
- small cell lung cancer
- nonsmall cell lung carcinoma
- impact of pet lung cancer
- pet on the management lung cancer
- clinical stage lung cancer
- thoracic staging lung cancer
- referring physician lung cancer
- prospective comparison lung cancer
- management plan lung cancer
- impact on management prognostic stratification
- powerful correlation high impact
- fdg pet response assessment
- radiotherapy candidates high impact
- thoracic staging therapeutic decisions
- clinical impact lung cancer
- impact of pet referring physician